U
Home> Startups> Immunorizon > Financials

Immunorizon

Former names: ExploreBio1
T-and NK-cell Engagers for Cancer Therapy
Startup Acquired Founded 2017 Health Tech & Life Sciences
Last Update Mar 16, 2025
OverviewBusinessFinancialsLifecycleNewsTeamSimilar companiesInternal

Immunorizon Financials

Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Acquired
Funding stage
3
Total rounds
2
Investors

Cumulative Funding Raised Over Time ($)

—Apr 2019
—Dec 2017
—Feb 2020

Private Equity Funding

Seed Feb 2020
Undisclosed
M Ventures
Seed Apr 2019
Undisclosed
M Ventures
Seed Dec 2017
Undisclosed
M Ventures, ExploreBio

Public Offering / Exit

MNAEvent Feb 2023
$100M